OTCMKTS:SGBI - Sangui Biotech International Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0229 -0.01 (-21.03 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close$0.0290
Today's Range$0.0229 - $0.0229
52-Week Range$0.0150 - $0.0790
Volume1,000 shs
Average Volume15,100 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through Internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is based in Witten, Germany.

Receive SGBI News and Ratings via Email

Sign-up to receive the latest news and ratings for SGBI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SGBI
CUSIPN/A
Phone+49-2302-915200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1
OptionableNot Optionable

Sangui Biotech International (OTCMKTS:SGBI) Frequently Asked Questions

What is Sangui Biotech International's stock symbol?

Sangui Biotech International trades on the OTCMKTS under the ticker symbol "SGBI."

Has Sangui Biotech International been receiving favorable news coverage?

Headlines about SGBI stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sangui Biotech International earned a news impact score of -1.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days.

Who are some of Sangui Biotech International's key competitors?

Who are Sangui Biotech International's key executives?

Sangui Biotech International's management team includes the folowing people:
  • Mr. Thomas Striepe, CEO, Pres, CFO & Exec. Director (Age 54)

How do I buy shares of Sangui Biotech International?

Shares of SGBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sangui Biotech International's stock price today?

One share of SGBI stock can currently be purchased for approximately $0.0229.

What is Sangui Biotech International's official website?

The official website for Sangui Biotech International is http://www.sanguibiotech.com/.

How can I contact Sangui Biotech International?

Sangui Biotech International's mailing address is c/o SanguiBioTech GmbH Alfred-Herrhausen-Str. 44, WITTEN, UT 58455, Germany. The company can be reached via phone at +49-2302-915200.


MarketBeat Community Rating for Sangui Biotech International (OTCMKTS SGBI)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  11 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Sangui Biotech International and other stocks. Vote "Outperform" if you believe SGBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SGBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2019 by MarketBeat.com Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel